| Entry |
|
|---|
| Name |
Didanosine (JAN/USP/INN);
Videx (TN) |
|---|
| Abbr |
ddI |
|---|
| Formula |
C10H12N4O3
|
|---|
| Exact mass |
236.0909
|
|---|
| Mol weight |
236.2273
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antiviral, Reverse transcriptase inhibitor |
|---|
| Disease |
|
|---|
| Target |
HIV-1 reverse transcriptase [KO: K24802] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF02 Didanosine
D00296 Didanosine (JAN/USP/INN)
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D00296 Didanosine
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
D00296 Didanosine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D00296 Didanosine (JAN/USP/INN)
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D00296 Didanosine (JAN/USP/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 C1y C 21.4753 -18.6138
2 C1x C 21.9474 -19.9309
3 C1x C 23.2760 -19.9589
4 C1y C 23.7382 -18.5458
5 O2x O 22.5821 -17.7578
6 N4y N 24.8502 -17.9061
7 C8y C 26.1874 -17.4796
8 C8y C 26.1962 -16.0801
9 N5x N 24.8679 -15.6394
10 N5x N 27.3950 -18.1870
11 C8x C 28.6114 -17.4947
12 N4x N 28.6201 -16.0953
13 C8y C 27.4125 -15.3880
14 O5x O 27.4212 -13.9796
15 C1b C 20.1331 -18.2217
16 O1a O 19.1456 -19.1655
17 C8x C 23.9301 -16.7382
BOND 19
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 6 7 1
7 7 8 2
8 7 10 1
9 10 11 2
10 11 12 1
11 12 13 1
12 8 13 1
13 13 14 2
14 4 6 1 #Up
15 1 15 1 #Up
16 15 16 1
17 9 17 2
18 17 6 1
19 9 8 1
|
|---|
